Literature DB >> 15285030

Assessment of correlation between serum titers of hepatitis C virus and severity of liver disease.

Bhupinder-S Anand1, Maria Velez.   

Abstract

AIM: The significance of hepatitis C virus (HCV) serum titers has been examined in several clinical situations. There is much evidence that patients with a lower viral load have better response rates to anti-viral therapy compared to those with higher levels. Moreover, a direct association has been observed between serum titers of HCV and transmission rates of the virus. The aim of the present study was to determine if there was any correlation between HCV viral load and the severity of liver disease.
METHODS: Fifty patients with HCV infection were included in the study. These comprised of 34 subjects with a history of alcohol use and 16 non-alcoholics. Quantitative serum HCV RNA assay was carried out using the branched DNA (bDNA) technique. Linear regression analysis was performed between serum viral titers and liver tests. In addition, for the purpose of comparison, the subjects were divided into two groups: those with low viral titers (< or = 50 genome mEq/mL) and high titers (> 50 mEq/mL).
RESULTS: All subjects were men, with a mean +/- SD age of 47 +/- 7.8 years. The mean HCV RNA level in the blood was 76.3 x 10(5) +/- 109.1 genome equivalents/mL. There was no correlation between HCV RNA levels and age of the patients (r = 0.181), and the history or amount (g/d) of alcohol consumption (r = 0.07). Furthermore, no correlation was observed between serum HCV RNA levels and the severity of liver disease as judged by the values of serum albumin (r = 0.175), bilirubin (r = 0.217), ALT (r = 0.06) and AST (r = 0.004) levels. Similarly, no significant difference was observed between patients with low viral titers and high titers with respect to any of the parameters.
CONCLUSION: Our results indicate that the severity of liver disease is independent of serum levels of hepatitis C virus. These findings are important since they have a direct impact on the current debate regarding the role of direct cytopathic effect of hepatitis C virus versus immune-mediated injury in the pathogenesis of HCV-related liver damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15285030      PMCID: PMC4576299          DOI: 10.3748/wjg.v10.i16.2409

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C.

Authors:  D R Nelson; C G Marousis; G L Davis; C M Rice; J Wong; M Houghton; J Y Lau
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

2.  Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population.

Authors:  L Fanning; E Kenny; M Sheehan; B Cannon; M Whelton; J O'Connell; J K Collins; F Shanahan
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

Review 3.  Interaction between the hepatitis C virus and the immune system.

Authors:  B Rehermann
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

4.  Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease.

Authors:  N Kato; O Yokosuka; K Hosoda; Y Ito; M Ohto; M Omata
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

5.  Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States.

Authors:  J Y Lau; M Mizokami; J A Kolberg; G L Davis; L E Prescott; T Ohno; R P Perrillo; K L Lindsay; R G Gish; K P Qian
Journal:  J Infect Dis       Date:  1995-02       Impact factor: 5.226

6.  Hepatitis C virus in alcoholic patients with and without clinically apparent liver disease.

Authors:  M E Coelho-Little; L J Jeffers; D E Bernstein; J J Goodman; K R Reddy; M de Medina; X Li; M Hill; S La Rue; E R Schiff
Journal:  Alcohol Clin Exp Res       Date:  1995-10       Impact factor: 3.455

7.  Clinical outcomes after transfusion-associated hepatitis C.

Authors:  M J Tong; N S el-Farra; A R Reikes; R L Co
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

8.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

9.  Clinical significance of serum hepatitis C virus titers in patients with chronic type C hepatitis.

Authors:  J H Kao; M Y Lai; P J Chen; L H Hwang; W Chen; D S Chen
Journal:  Am J Gastroenterol       Date:  1996-03       Impact factor: 10.864

10.  Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group.

Authors:  J Y Lau; G L Davis; L E Prescott; G Maertens; K L Lindsay; K Qian; M Mizokami; P Simmonds
Journal:  Ann Intern Med       Date:  1996-05-15       Impact factor: 25.391

View more
  6 in total

1.  Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.

Authors:  Shawky Abdelhamid Fouad; Serag Esmat; Dalia Omran; Laila Rashid; Mohamed H Kobaisi
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

2.  Identification of a previously undescribed divergent virus from the Flaviviridae family in an outbreak of equine serum hepatitis.

Authors:  Sanjay Chandriani; Peter Skewes-Cox; Weidong Zhong; Donald E Ganem; Thomas J Divers; Anita J Van Blaricum; Bud C Tennant; Amy L Kistler
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

Review 3.  Challenges of recurrent hepatitis C in the liver transplant patient.

Authors:  Renumathy Dhanasekaran; Roberto J Firpi
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

4.  Circulating viral core and E1 antigen levels as supplemental markers for HCV chronic hepatitis.

Authors:  Mostafa K El Awady; Yasmine S El Abd; Hussein A Shoeb; Ashraf A Tabll; Alaa El Din M S Hosny; Reem M El Shenawy; Khaled Atef; Noha G Bader El Din; Mahmoud M Bahgat
Journal:  Virol J       Date:  2006-09-01       Impact factor: 4.099

5.  Hepatitis C virus load in parenchyma cells correlates with hepatic injury in infected patients.

Authors:  Zhen Xu; Ji-Zong Lin; Guo-Li Lin; Fang-Fang Wei; Jing Liu; Zhi-Xin Zhao; Ying Zhang; Wei-Ming Ke; Xiao-Hong Zhang
Journal:  Exp Ther Med       Date:  2016-11-18       Impact factor: 2.447

6.  Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort Study.

Authors:  Joon Yeul Nam; Eun Sun Jang; Young Seok Kim; Youn Jae Lee; In Hee Kim; Sung Bum Cho; Han Chu Lee; Si Hyun Bae; Moran Ki; Hwa Young Choi; Eun Young Lee; Sook-Hyang Jeong
Journal:  Gut Liver       Date:  2020-03-15       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.